Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Prostate Cancer and Prostatic Diseases
|
April 29, 2022
Prostate cancer intensity-modulated radiotherapy and long term genitourinary toxicity: an evolving therapeutic landscape
Vérane Achard, Thomas Zilli
International Journal of Radiation Oncology, Biology, Physics
|
February 25, 2020
In Regard to Qi et al
Vérane Achard, Thomas Zilli
International Journal of Radiation Oncology, Biology, Physics
|
October 31, 2024
Chemoradiation Therapy for Nonmetastatic Muscle-Invasive Bladder Cancer: Still the Only Bladder Preservation Treatment in 2024
Vérane Achard, Robert Huddart
Prostate Cancer and Prostatic Diseases
|
August 13, 2024
Current status and perspectives on the use of androgen receptor pathway inhibitors in the salvage radiotherapy setting
Vérane Achard, Thomas Zilli
Prostate Cancer and Prostatic Diseases
|
December 8, 2023
High-risk biochemical recurrence of locally treated prostate cancer after EMBARK. An end to decades of conventional wisdom?
Vérane Achard, Bertrand Tombal
International Journal of Radiation Oncology, Biology, Physics
|
March 23, 2020
Letter from Switzerland
Vérane Achard, Pelagia Tsoutsou, Thomas Zilli
European Urology Open Science
|
February 3, 2026
Re: Amar U. Kishan, Luca F. Valle, Holly Wilhalme, et al. <sup>177</sup>Lu-Prostate-specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-label, Randomized, Controlled, Phase II Study. J Clin Oncol 2025;43:3812-21
Vérane Achard, Thomas Zilli, Bertrand Tombal
Revue Medicale Suisse
|
May 29, 2020
[Metastatic hormone-sensitive prostate cancer: more than just androgen-deprivation therapy]
Hiba Mechahougui, Vérane Achard, Alex Friedlaender
Seminars in Radiation Oncology
|
June 14, 2025
Postoperative Radiation Therapy and Controversies Regarding Hormonal Therapy in the Management of Prostate Cancer
Vérane Achard, Alan Dal Pra, Paul Sargos
European Urology
|
October 3, 2020
Re: Carlo A. Bravi, Nicoal Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9
Vérane Achard, Alan Dal Pra, Thomas Zilli
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Prostate Cancer and Prostatic Diseases
|
April 29, 2022
Prostate cancer intensity-modulated radiotherapy and long term genitourinary toxicity: an evolving therapeutic landscape
Vérane Achard, Thomas Zilli
International Journal of Radiation Oncology, Biology, Physics
|
February 25, 2020
In Regard to Qi et al
Vérane Achard, Thomas Zilli
International Journal of Radiation Oncology, Biology, Physics
|
October 31, 2024
Chemoradiation Therapy for Nonmetastatic Muscle-Invasive Bladder Cancer: Still the Only Bladder Preservation Treatment in 2024
Vérane Achard, Robert Huddart
Prostate Cancer and Prostatic Diseases
|
August 13, 2024
Current status and perspectives on the use of androgen receptor pathway inhibitors in the salvage radiotherapy setting
Vérane Achard, Thomas Zilli
Prostate Cancer and Prostatic Diseases
|
December 8, 2023
High-risk biochemical recurrence of locally treated prostate cancer after EMBARK. An end to decades of conventional wisdom?
Vérane Achard, Bertrand Tombal
International Journal of Radiation Oncology, Biology, Physics
|
March 23, 2020
Letter from Switzerland
Vérane Achard, Pelagia Tsoutsou, Thomas Zilli
European Urology Open Science
|
February 3, 2026
Re: Amar U. Kishan, Luca F. Valle, Holly Wilhalme, et al. <sup>177</sup>Lu-Prostate-specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-label, Randomized, Controlled, Phase II Study. J Clin Oncol 2025;43:3812-21
Vérane Achard, Thomas Zilli, Bertrand Tombal
Revue Medicale Suisse
|
May 29, 2020
[Metastatic hormone-sensitive prostate cancer: more than just androgen-deprivation therapy]
Hiba Mechahougui, Vérane Achard, Alex Friedlaender
Seminars in Radiation Oncology
|
June 14, 2025
Postoperative Radiation Therapy and Controversies Regarding Hormonal Therapy in the Management of Prostate Cancer
Vérane Achard, Alan Dal Pra, Paul Sargos
European Urology
|
October 3, 2020
Re: Carlo A. Bravi, Nicoal Fossati, Giorgio Gandaglia, et al. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought. Eur Urol 2020;78:661-9
Vérane Achard, Alan Dal Pra, Thomas Zilli
Page
of 6